000			01176 a2200337 4500
005			20250517042808.0
264		0	_c20160504
008			201605s 0 0 ger d
022			_a1433-0407
024	7		_a10.1007/s00115-015-4388-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aWinkelmann, A
245	0	0	_a[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs]. _h[electronic resource]
260			_bDer Nervenarzt _cAug 2015
300			_a971-7 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadverse effects
650	0	4	_aImmunotherapy _xadverse effects
650	0	4	_aInfection Control _xmethods
650	0	4	_aInfections _xchemically induced
650	0	4	_aInfusions, Intravenous
650	0	4	_aMultiple Sclerosis _xcomplications
650	0	4	_aSelf Administration _xadverse effects
700	1		_aLöbermann, M
700	1		_aReisinger, E C
700	1		_aHartung, H-P
700	1		_aZettl, U K
773	0		_tDer Nervenarzt _gvol. 86 _gno. 8 _gp. 971-7
856	4	0	_uhttps://doi.org/10.1007/s00115-015-4388-4 _zAvailable from publisher's website
999			_c25086578 _d25086578